Adient (ADNT) Upgraded to “Overweight” by Barclays

Barclays upgraded shares of Adient (NYSE:ADNT) from an equal weight rating to an overweight rating in a research note published on Tuesday morning, BenzingaRatingsTable reports. They currently have $30.00 target price on the stock, up from their previous target price of $16.00.

A number of other brokerages have also weighed in on ADNT. Bank of America raised shares of Adient from a neutral rating to a buy rating and set a $25.00 target price on the stock in a research note on Friday, April 12th. Wells Fargo & Co reaffirmed a hold rating on shares of Adient in a research note on Thursday, February 7th. ValuEngine lowered shares of Adient from a sell rating to a strong sell rating in a research note on Tuesday, March 5th. Zacks Investment Research raised shares of Adient from a strong sell rating to a hold rating in a research note on Monday, January 14th. Finally, Robert W. Baird lowered shares of Adient from a neutral rating to an underperform rating and cut their target price for the company from $25.00 to $14.00 in a research note on Friday, January 4th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of $31.85.

ADNT stock opened at $24.48 on Tuesday. Adient has a 12-month low of $12.15 and a 12-month high of $66.15. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 4.83 and a beta of 2.09. The company has a debt-to-equity ratio of 1.25, a quick ratio of 0.77 and a current ratio of 1.00.

Adient (NYSE:ADNT) last released its quarterly earnings data on Thursday, February 7th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.17). Adient had a negative net margin of 8.54% and a positive return on equity of 13.15%. The firm had revenue of $4.16 billion during the quarter, compared to analysts’ expectations of $4.17 billion. During the same quarter in the previous year, the firm posted $1.06 EPS. Adient’s revenue was down 1.1% compared to the same quarter last year. As a group, equities analysts predict that Adient will post 2.33 EPS for the current year.

A number of large investors have recently bought and sold shares of the stock. Parametrica Management Ltd bought a new position in shares of Adient in the fourth quarter worth approximately $328,000. Vanguard Group Inc. lifted its stake in shares of Adient by 7.0% in the third quarter. Vanguard Group Inc. now owns 1,688,703 shares of the company’s stock worth $66,383,000 after buying an additional 110,884 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of Adient by 111.2% in the third quarter. The Manufacturers Life Insurance Company now owns 265,881 shares of the company’s stock worth $10,452,000 after buying an additional 139,963 shares in the last quarter. Legal & General Group Plc lifted its stake in shares of Adient by 22.4% in the third quarter. Legal & General Group Plc now owns 459,373 shares of the company’s stock worth $18,058,000 after buying an additional 83,996 shares in the last quarter. Finally, Hutchinson Capital Management CA lifted its stake in shares of Adient by 172.5% in the fourth quarter. Hutchinson Capital Management CA now owns 518,233 shares of the company’s stock worth $7,804,000 after buying an additional 328,063 shares in the last quarter.

About Adient

Adient plc designs, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. It operates through three segments: Seating, Seat Structures and Mechanisms (SS&M), and Interiors. The Seating segment produces seat systems for automotive and other mobility applications, as well as various components of seat systems, including foams, trims, and fabrics.

Further Reading: What are gap-down stocks?

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit